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Abstract
The burden of breast cancer in Vietnam has not been documented. This study sought to
estimate the incidence of breast cancer in Ho Chi Minh City, the largest economic center of
Vietnam, from 1996 to 2015. This was a population-based study using the Ho Chi Minh City
Cancer Registry as a source of data (coverage period: 1996–2015). The Registry adopted
the International Classification of Diseases for Oncology, 3rd Edition for the classification of
primary sites and morphology, and guidelines from the International Agency for Research
on Cancer and the International Association of Cancer Registries. Using the population sta-
tistics from census data of Ho Chi Minh City, the point incidence of breast cancer for 5-year
period was estimated. Based on the national population, we calculated the age-standard-
ized rate (ASR) of breast cancer between 1996 and 2015. Overall 14,222 new cases of
breast cancer (13,948 women, or 98%) had been registered during the 1996–2015 period;
among whom, just over half (52%) were in the 2nd stage and 26% in the 3rd and 4th stages.
In women, the median age at diagnosis was 50 years and there was a slight increase over
time. The ASR of breast cancer during the 2011–2015 period was 107.4 cases per 100,000
women, representing an increase of 70% compared to the rate during the 1996–2000
period. In men, there was also a significant increase in the ASR: from 1.13 during the 1996–
2001 period to 2.32 per 100,000 men during the 2011–2015 period. These very first data
from Vietnam suggest that although the incidence of breast cancer in Vietnam remains rela-
tively low, it has increased over time.
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Introduction
Breast cancer is the most common cancer in women worldwide. In the United States alone,
projected statistics in 2019 showed that approximately 30% of all cancers in women were
attributable to breast cancer [1, 2]. Moreover, in the Asia Pacific region, incomplete data indi-
cate that breast cancer was the most common type of cancer, accounting for 18% of total can-
cers in women [3]. In absolute number, the International Agency for Research on Cancer
(IARC) estimated that in 2018 alone, 2.1 million women were diagnosed with breast cancer,
and 627 women died from the disease [4]. With the rapid aging of the population worldwide,
the burden of breast cancer is expected to increase in the future.
There is a geographic disparity in the distribution of breast cancers. At present, the inci-
dence of breast cancer in Asian populations is lower than in white populations. The age-
adjusted incidence rate of cancer in Asian populations was 29 per 100,000 women, which is
about a third of that in the American population (~93 per 100,000 women); however, the risk
of mortality from breast cancer in Asians is higher than that in women of European descent
[5]. More interestingly, Asian women tend to have breast cancer at a younger age than their
white counterparts: 47% of women with a diagnosis of breast cancers aged 50 years or younger,
but this proportion was 33% in the world [3].
Although there have been extensive studies on breast cancer in economically advantaged
countries, the incidence, prevalence, and risk factors for breast cancer in Vietnam have not
been well documented. Results from one case-control study found that breast density, age at
first menarche, menopause status, number of pregnancies, number of babies born, hormone
use and no physical activities were significantly associated with breast cancer in Vietnamese
women [6]. Vietnam is the 15th most populous country in the world, with a population of 97
million [7]. Almost 23% of the population aged 50 years and older. However, until now, there
has been no systematic documentation of the incidence of breast cancer in Vietnam over the
past 20 years. In this study, we sought to estimate the incidence of breast cancer in Ho Chi
Minh City, the largest city in Vietnam. Our result provides important data concerning the bur-
den of breast cancer in the country that is rapidly transiting from an agricultural economy to a
modern economy.
Study design and methods
The anonymized data for this study were extracted from the Ho Chi Minh City Cancer Regis-
try. The Registry was established in 1990 to document all diagnosed cancer cases in the City.
Cancer patients admitted to any hospital in the City were ascertained and checked for possible
duplication. The coverage period was from January 1, 1996 to December 31, 2015. This study
was restricted to people who were identified as residents of Ho Chi Minh City on their patient
records. We focused on Ho Chi Minh City, because (i) it is the largest center of commerce in
the country, with a population of 8.2 million (2014 statistics); (ii) the ascertainment and docu-
mentation of cancers in the City is more complete than any other provinces in the country;
and (iii) the City offers an opportunistic setting for studying the burden of cancers in a transi-
tional population. The study was approved by the Ethics Committee of the Oncology Hospital
of Ho Chi Minh City. Because all data were anonymized no individual patient consent was
required.
The Ho Chi Minh City Cancer Registry adopted the International Classification of Diseases
for Oncology, 3rd Edition (ICDO-3) for the classification of primary sites and morphology,
and guidelines from the International Agency for Research on Cancer and the International
Association of Cancer Registries. Based on the ICDO-3, we identified breast cancer cases from
PLOS ONE Trends in breast cancer incidence in Vietnam
PLOS ONE | https://doi.org/10.1371/journal.pone.0246800 February 10, 2021 2 / 8
and middle-income context. Registry data are
stored in a computerized data at the Oncology
Hospital of Ho Chi Minh City. The dataset includes
the following variables: age, sex, diagnosis, year of
diagnosis, cancer stage, treatment, and survival
status. All authors had no special access privileges
in accessing these datasets which other interested
researchers would not have. Age-and-gender
population statistics were obtained from census
data managed by the General Statistics Office
(GSO) of Ho Chi Minh City. Age-and-gender
population statistics in 1999 for Vietnam was
obtained from the Bureau of Statistics of Vietnam.
There is no URL for the population data. However,
request for data access can be made to the General
Statistics Office of Ho Chi Minh City, contact
through email tdnlinh@ump.edu.vn.
Funding: The authors received no specific funding
for this work.
Competing interests: The authors have declared
that no competing interests exist.
1 January 1996 to 31 December 2015 inclusive. The identification was further ascertained by
tumor site code, morphology code, and behavior type.
Data from all registries was collected and assessed based on guidelines from the Interna-
tional Agency for Research on Cancer and the International Association of Cancer Registries,
adapted to a low and middle-income context. Data was validated through clinical records,
coded, and verified according to guidelines.
Age-and-gender population statistics were obtained from census data managed by the Gen-
eral Statistics Office (GSO) of Ho Chi Minh City. Population statistics were available for 1999,
2004, 2009, and 2014. Age-and-gender population statistics in 1999 for Vietnam were obtained
from the Bureau of Statistics of Vietnam.
Using the population statistics of Ho Chi Minh City, we computed the point incidence
rate of breast cancer (per 100,000 population) for each 5-year interval: 1996–2000, 2001–
2005, 2006–2010, and 2011–2015 inclusive. The reason for aggregating 5-year data was to
improve the stability of statistical estimates. We used the direct method of standardization to
calculate the age-standardized rate (ASR), by applying the age-specific rates observed in a
period to the national population in 1999. In this approach, the ASR can be thought of as a
weighted average rate, with the weights being the proportion of the national population in
each age group.
We employed a logistic joint point regression model [8] to identify temporal changes in the
incidence of breast cancer over the coverage period. Assuming that the annual incidence of
cases in the population follows the Binomial distribution, the logistic joint point regression
uses the logit of the incidence rate as the dependent variable to identify the best fit for joint
points (i.e., inflexion points) at which there is a significant change in trends. Based on explor-
atory analysis, we allowed maximum of 2 points in the model. The analyses were conducted
using the R Statistical Environment [9] and "ljr" package [8].
Results
Between January 1, 1996 and December 31, 2015, 14,222 new cases of breast cancer (13,948
women, or 98%) had been registered in the Registry (Table 1). Almost 100% of cancers were
classified as malignant. Based on the data on stage (n = 422 women), just over half (52%) were
in the 2nd stage, and 26% of cases were in the 3rd and 4th stages.
The median age at diagnosis was 50 years (IQR: 43–59) and 55 years (IQR: 47–65) for
women and men, respectively. In women, there was a slight but statistically significant increase
in the average age of diagnosis of breast cancer between 1996 and 2015. Between 1996 and
2000, the median age at diagnosis was 49, and this was increased to 51 yrs during 2011 and
2015 (P = 0.006). Between 1996 and 2000, 48.8% of women with a breast cancer diagnosis aged
50 years and older, and this proportion was increased to 55.8% during 2011 and 2015
(Table 2).
Joint point regression analysis identified 2 breakpoints, 1999 and 2005, in the incidence of
breast cancer in women throughout 1996–2015 (Fig 1). The average rates of increase in the
incidence during the period of 1996–1999, 2000–2005, and 2006–2015 were 0.019, 0.001, and
0.013, respectively.
In women, the 5-year age-standardized incidence rate of breast cancer was 62.2 cases per
100,000 population during the 1996–2000 period, and this was progressively increased to 107.4
during the 2011–2015 period, representing a 70% increase over the 20-year period. In men,
there was also a significant increase in the age-standardized incidence rate: from 1.13 during
the 1996–2001 period to 2.32 during the 2011–2015 period, representing an increase of
2.1-fold (Table 3).
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Discussion
It has been projected that economically less developed countries are going to bear a greater
burden of breast cancer than more developed countries [10]. However, research on risk factors
for and incidence of breast cancer in population among less developed countries have been
scarce. In this study, by using a well-characterized registry-based data of the largest city in
Vietnam, we have shown that over the past 20 years, the incidence of breast cancer had
increased by 70% and that the increase was mainly attributable to those age groups of 50 and
70. These very first results from Vietnam deserves further elaboration.
It seems clear that the age-standardized incidence of breast cancer in this study is lower
than that in white populations. For instance, in the United States, between 2009 and 2016, the
age-standardized incidence rate was approximately 200 per 100,000 woman-years [11] which
is higher than in Australia (~131 per 100,000 women) [12]. In China, the age-standardized
Table 1. Clinical characteristics of 13948 women and 274 men with breast cancer in Ho Chi Minh City, 1996–2015.
Women (n = 13948) Men (n = 274) Total (n = 14222)
Type of cancer
In situ 44 (0.3%) 0 (0%) 44 (0.3%)
Malignant 13892 (99.6%) 274 (100%) 14166 (99.6%)
Uncertain 12 (0.1%) 0 (0%) 12 (0.1%)
Stage of cancer
I 87 (0.6%) 0 (0%) 87 (0.6%)
II 223 (1.6%) 4 (1.5%) 227 (1.6%)
III 69 (0.5%) 0 (0%) 69 (0.5%)
IV 43 (0.3%) 1 (0.4%) 44 (0.3%)
Unknown 13525 (97.0%) 269 (98.2%) 13794 (97.0%)
Base of Diagnostic
Biochemical/Immuno tests 6 (0.0%) 0 (0%) 6 (0.0%)
Clinical examination only 40 (0.3%) 1 (0.4%) 41 (0.3%)
Clinical test 1066 (7.6%) 25 (9.1%) 1091 (7.7%)
Cytology/Haematology 1284 (9.2%) 19 (6.9%) 1303 (9.2%)
Exploratory surgery 270 (1.9%) 6 (2.2%) 276 (1.9%)
Histology of Metastasis 214 (1.5%) 6 (2.2%) 220 (1.5%)
Histology of Primary 11033 (79.1%) 217 (79.2%) 11250 (79.1%)
Missing 35 (0.3%) 0 (0%) 35 (0.2%)
Treatment
Chemotherapy 1523 (10.9%) 27 (9.9%) 1550 (10.9%)
Hormonotherapy 38 (0.3%) 1 (0.4%) 39 (0.3%)
No treatment 2527 (18.1%) 56 (20.4%) 2583 (18.2%)
Others 80 (0.6%) 3 (1.1%) 83 (0.6%)
Radiotherapy 96 (0.7%) 24 (8.8%) 120 (0.8%)
Surgery 9543 (68.4%) 161 (58.8%) 9704 (68.2%)
Missing 141 (1.0%) 2 (0.7%) 143 (1.0%)
Status
Alive 13437 (96.3%) 260 (94.9%) 13697 (96.3%)
Dead 101 (0.7%) 4 (1.5%) 105 (0.7%)
Unknown 354 (2.5%) 10 (3.6%) 364 (2.6%)
Missing 56 (0.4%) 0 (0%) 56 (0.4%)
Note: number in bracket represents the column-wise percentage.
https://doi.org/10.1371/journal.pone.0246800.t001
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incidence of breast cancer was observed at 28.4 per 100,000 women [13]. In Vietnam’s neigh-
boring country Thailand, the incidence rate was estimated to be 31.2 per 100,000 woman-
years [14]. In our study, the annualized age-standardized incidence rate was 21.5 per 100,000
women throughout 2011 and 2015, which can still be considered low relative to populations in
more economically developed countries.
We found that the incidence of breast cancer in our cohort had been increasing over time,
and this trend is consistent with previous observations [15–17]. In the 1996–2000 period, the
age-standardized incidence rate was 12.4 per 100,000 women which is comparable with a pre-
vious estimate [18]. However, 20 years later, this incidence was increased by almost two-fold.
It has been projected that the incidence of all cancers in the two major cities of Vietnam will be
increased by approximately 17% over the next 5 years [19]. The increase in breast cancer inci-
dence rates has been found in China, Japan, and Thailand [20]. This increase in the incidence
plus the large population sizes in Asia imply that more cancer cases will be observed in Asian
populations than in white populations. The increase in life expectancy and the aging of the
population contribute three-fifths and the increased age-standardized rates contribute two-
fifths of future trend [21]. If this assumption holds and given the improvement in life expec-
tancy in Vietnamese women (~79.4 years) [22], it is expected that breast cancer will impose a
heavy burden in Vietnam shortly. The increase in cancer incidence could also reflect better
registration of cases and/or public awareness over the coverage period.
The age structure of cancer cases in our cohort merits a comment. We found that the
median age at diagnosis of breast cancer was 50 years (in women), which is almost identical to
the median age at diagnosis of breast cancer among Singaporean [23] and Korean [24]
women. In economically more developed countries, the average age at breast cancer diagnosis
was ~54 years [25] or 59 years [26]. Thus, our finding reaffirms the common ’law’ that Asian
women tended to have breast cancer at a younger age than their white counterparts.
Almost 100% of breast cancer tumors in this study were in the invasive stage, only 0.3% was
in situ, and 26% of cases were diagnosed at late stage III and IV. The proportion of in-situ
Table 2. Age distribution of breast cancer by age group and by sex in Ho Chi Minh City, Vietnam (1996–2015).
Gender Age group 1996–2000 2001–2005 2006–2010 2011–2015
Women <30 24 (1.3) 33 (1.2) 45 (1.2) 81 (1.5)
30–39 256 (13.4) 368 (12.9) 457 (12.0) 622 (11.6)
40–49 702 (36.7) 1090 (38.3) 1310 (34.3) 1668 (31.1)
50–59 431 (22.5) 726 (25.5) 1194 (31.3) 1749 (32.6)
60–69 302 (15.8) 401 (14.1) 519 (13.6) 834 (15.5)
70–79 153 (8.0) 182 (6.4) 224 (5.9) 326 (6.1)
80+ 47 (2.5) 48 (1.7) 70 (1.8) 86 (1.6)
All ages 1915 2848 3819 5366
Men <30 0 0 2 (2.4) 1 (1.0)
30–39 3 (9.7) 10 (16.9) 4 (4.7) 7 (7.1)
40–49 10 (32.3) 9 (15.3) 22 (25.9) 24 (24.2)
50–59 8 (25.8) 12 (20.3) 26 (30.6) 29 (29.3)
60–69 7 (22.6) 13 (22.0) 10 (11.8) 23 (23.2)
70–79 2 (6.5) 10 (16.9) 18 (21.2) 14 (14.1)
80+ 1 (3.2) 5 (8.5) 3 (3.5) 1 (1.0)
All ages 31 59 85 99
Note: numbers in brackets represent the sex-specific percent of the total for each 5-year interval.
https://doi.org/10.1371/journal.pone.0246800.t002
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tumors was 16% in the United States [27] and 14% in South Korea [24]. Delayed diagnosis of
cancer is a major factor that contributes to the increased risk of premature death, lower cancer
survival and increases the burden of cancer. Indeed, the overall 5-year relative survival rate is
99% for localized disease, 85% for regional disease and 27% for distant-stage disease [28]. Our
finding implies that a more aggressive screening strategy for identifying cancer cases earlier is
warranted.
Fig 1. Estimated annual incidence rate of breast cancer (per 1000 population) in women during the 1996–2015 period in Ho Chi Minh City.
https://doi.org/10.1371/journal.pone.0246800.g001
Table 3. Unadjusted and standardized incidence rate (per 100,000 persons over 5 years) of breast cancer in Ho Chi Minh City (1996–2015) stratified by gender.
Gender Estimate 1996–2000 2001–2005 2006–2010 2011–2015
Women Unadjusted 73.3 (1.67) 89.7 (1.68) 102.5 (1.66) 137.1 (1.87)
Standardized 62.2 (0.38) 72.5 (0.41) 79.3 (0.43) 107.4 (0.51)
Rate Ratio 1.00 1.20 1.30 1.70
Men Unadjusted 1.28 (0.23) 2.01 (0.26) 2.47 (0.27) 2.74 (0.28)
Standardized 1.13 (0.05) 1.77 (0.06) 2.01 (0.07) 2.32 (0.08)
Rate Ratio 1.00 1.60 1.80 2.10
Note: numbers in brackets represent standard error.
https://doi.org/10.1371/journal.pone.0246800.t003
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Our findings should be interpreted within the context of the study’s strengths and weak-
nesses. The data were ascertained from a well-developed registry that could capture total can-
cer incidence in Ho Chi Minh City. It is worth noting that virtually all breast cancer cases are
treated at hospitals within the City, with a very small proportion being treated overseas, and
the data were therefore likely complete. However, a caveat of the study is that we could not fol-
low individual patients to ascertain their survival status, and as a result, we could not analyze
the rate of mortality among these patients. Moreover, our finding concerning incidence may
not be generalized to rural or non-urban areas where the incidence is expected to be lower
than that in urban areas.
In conclusion, our registry-based data suggest that although breast cancer incidence in Ho
Chi Minh City remained relatively low compared to white populations, there was an increasing
trend up to 70% over the past 20 years. Our data also confirm that Vietnamese women tend to
have breast cancer at younger ages compared to white women. These findings imply that
breast cancer screening should be targeted women of younger ages.
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